Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Cara Therapeutics Inc
CARA
$
15.62
4.2%
Tue November 10th, 2020
02:00
Earnings
Analysis
Cara Therapeutics Inc (CARA) Q3 2020 Earnings Call Transcript
The Motley Fool
01:01
Earnings
Analysis
Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha
Mon November 9th, 2020
22:25
Analysis
Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates
Zacks
Thu October 22nd, 2020
16:00
Analysis
Cara (CARA) Moves to Buy: Rationale Behind the Upgrade
Zacks
Tue August 11th, 2020
00:28
Earnings
Analysis
Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Mon August 10th, 2020
22:05
Analysis
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
Zacks
Wed July 29th, 2020
16:33
Earnings
Analysis
Analysts Estimate Cara Therapeutics (CARA) to Report a Decline in Earnings: What to Look Out for
Zacks
Sun June 28th, 2020
18:36
Analysis
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
The Motley Fool
